GLP2R

glucagon like peptide 2 receptor, the group of Glucagon receptor family

Basic information

Region (hg38): 17:9822206-9892099

Links

ENSG00000065325 ∙ NCBI:9340 ∙ OMIM:603659 ∙ HGNC:4325 ∙ Uniprot:O95838 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GLP2R gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLP2R gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous					2	2
missense			22	3	6	31
nonsense						0
start loss						0
frameshift						0
inframe indel						0
splice donor/acceptor (+/-2bp)						0
splice region						0
non coding						0
Total	0	0	22	3	8

Variants in GLP2R

This is a list of pathogenic ClinVar variants found in the GLP2R region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
17-9826074-G-A		not specified	Uncertain significance (Dec 03, 2021)
17-9826094-G-A		not specified	Uncertain significance (Jan 29, 2024)
17-9826106-G-A		not specified	Uncertain significance (Sep 16, 2021)
17-9826128-A-T			Benign (May 31, 2018)
17-9826130-G-A		not specified	Uncertain significance (Jan 26, 2022)
17-9833847-C-T		not specified	Uncertain significance (Sep 25, 2024)
17-9833888-C-G			Benign (Jun 29, 2018)
17-9836384-C-T			Benign (Jul 26, 2018)
17-9842561-C-T		not specified	Uncertain significance (Nov 17, 2023)
17-9842563-G-A		not specified	Uncertain significance (Sep 04, 2024)
17-9854502-G-A		not specified	Likely benign (Jun 26, 2023)
17-9854573-C-G		not specified	Uncertain significance (Jun 30, 2022)
17-9854588-C-T		not specified	Uncertain significance (Nov 24, 2024)
17-9857438-G-A			Benign (Jun 11, 2018)
17-9857482-G-A		not specified	Uncertain significance (Aug 13, 2021)
17-9857500-T-C		not specified	Uncertain significance (Nov 08, 2021)
17-9857508-G-A		not specified	Uncertain significance (Nov 08, 2022)
17-9857571-T-A		not specified	Uncertain significance (Oct 03, 2024)
17-9857575-A-C			Benign (Jul 13, 2018)
17-9859957-C-T		not specified	Uncertain significance (Nov 17, 2023)
17-9860069-G-A		not specified	Uncertain significance (Nov 08, 2022)
17-9861177-C-T		not specified	Uncertain significance (Feb 28, 2023)
17-9861198-G-A		not specified	Uncertain significance (Jan 23, 2023)
17-9862050-T-G		not specified	Uncertain significance (Oct 12, 2021)
17-9870807-C-A		not specified	Uncertain significance (Mar 02, 2023)

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
GLP2R	protein_coding	protein_coding	ENST00000262441	13	69897

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
2.64e-11	0.882	125676	0	71	125747	0.000282

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	1.16	251	308	0.814	0.0000172	3551
Missense in Polyphen		67	109.19	0.61361		1321
Synonymous	-0.524	131	124	1.06	0.00000693	1102
Loss of Function	1.88	22	33.8	0.652	0.00000184	363

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.00150	0.00150
Ashkenazi Jewish	0.000107	0.0000992
East Asian	0.0000544	0.0000544
Finnish	0.0000463	0.0000462
European (Non-Finnish)	0.000144	0.000141
Middle Eastern	0.0000544	0.0000544
South Asian	0.000137	0.000131
Other	0.000170	0.000163

dbNSFP

Source: dbNSFP

• Function: FUNCTION: This is a receptor for glucagon-like peptide 2. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
• Pathway: Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class B Secretin-like;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Glucagon-type ligand receptors;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR downstream signalling (Consensus)

Recessive Scores

• pRec: 0.147

Intolerance Scores

• loftool: 0.824
• rvis_EVS: 1.02
• rvis_percentile_EVS: 91.05

Haploinsufficiency Scores

• pHI: 0.0600
• hipred: N
• hipred_score: 0.281

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: N
• gene_indispensability_score: 0.354

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Glp2r
• Phenotype: digestive/alimentary phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); neoplasm; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype

Gene ontology

• Biological process: cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;positive regulation of cell population proliferation;cellular response to glucagon stimulus
• Cellular component: plasma membrane;integral component of membrane
• Molecular function: G protein-coupled receptor activity;glucagon receptor activity;G protein-coupled peptide receptor activity;peptide hormone binding